Protocol logistics
Beyond-use dates and expiry dates are not the same date
On this page
An expiry date applies to an unopened container stored as its label says, and it is backed by stability data the manufacturer generated for that product in that container.
A beyond-use date applies once a preparation has been made, entered or altered. It is derived from the conditions under which the work was done, not from a property of the liquid.
Because a beyond-use date is an output of conditions, it does not travel. Change the environment and the standard produces a different figure, or no figure at all.
For anything prepared outside a controlled compounding environment there is no validated beyond-use dating — not a longer number, not a shorter one.
This page explains where two kinds of date come from. Where it quotes an interval, it is quoting a published guideline for clinical settings and says so. It does not tell you how long anything you hold lasts, and no interval on this page should be read as applying to a preparation made outside the setting the guideline describes.
Where an expiry date comes from
An expiration date is not an estimate someone printed on a box. Under US drug manufacturing regulations it must be determined by appropriate stability testing, and there must be a written testing programme designed to assess the stability characteristics of the product, with results used to determine appropriate storage conditions and the expiration date itself.12
International stability guidance describes the shape of that programme: samples of defined batches held in the container-closure system the product is marketed in, at defined storage conditions, tested at defined intervals against defined attributes. The date that comes out the end is specific to that formulation, in that container, held those ways.3
Two consequences follow immediately. The date is meaningless outside the labelled storage conditions, because those conditions were an input to it. And the date says nothing about the same material after the closure has been entered, because the samples that generated it were not entered.36
Where a beyond-use date comes from
A beyond-use date is the date or time after which a preparation is not to be used, once it has been compounded, entered or otherwise altered. USP General Chapter <797> defines beyond-use dating for compounded sterile preparations, and defines it as a function of controlled variables: the classification of the compounding environment and its air quality, personnel training and garbing, the aseptic process used, whether sterility testing was performed, and the category the preparation falls into.4
This is the structural point of the whole page. The number is an output of the conditions, not a property of the liquid. Two identical preparations made in two different environments carry two different beyond-use dates, correctly. Nothing about the molecules differs; the confidence in the process does.4
The third date: the in-use period
Approved products commonly carry a third statement in their labelling — an in-use period that applies once a presentation has been entered or first used, alongside the storage conditions that apply before that point. It is product-specific and presentation-specific, reviewed as part of the approval, and it varies between products that look similar on a shelf.13
That variation is why a secondhand figure is worth so little. Detached from the product it belongs to, an in-use period is just a number someone remembers.
What clinical guidance says about entered containers
Guidance for supervised clinical settings does attach intervals to entered multi-dose containers. WHO's multi-dose vial policy, in its 2014 revision, sets out the conditions under which opened multi-dose vials of WHO pre-qualified vaccines can be kept for 28 days, and which must instead be discarded after six hours or at the end of the immunisation session, whichever comes first. Two intervals, for the same physical object, decided by which conditions were met.5
Those statements are quoted here for what they are: rules written for supervised settings, about specified products, with defined handling and storage behind them. They describe a practice, not a property of liquids, and they were not written about anything prepared at home.5
Why no figure exists for a home setting
Put the three sources side by side and the gap is visible rather than rhetorical. Expiry dating requires a stability programme with tested samples. Beyond-use dating requires a classified environment and a documented aseptic process. In-use periods require an approved label. A home setting supplies none of the three, so none of the three produces a number for it — not a shorter number, and not a longer one.234
Compounded preparations sit in a related but distinct position. FDA states plainly that compounded drugs are not FDA-approved and that the agency does not verify their safety, effectiveness or quality before marketing. Where there has been no review, there is no reviewed dating statement to read.7
What a record can carry when a date cannot
When no authoritative interval exists, the useful thing is not a guessed interval. It is a record precise enough that a clinician can reason about it later.
- The manufacturer's expiration date, transcribed from the container.
- The full timestamp at which the container was first entered or the preparation made, with timezone context.
- The diluent container used, identified well enough to trace back to its own label and lot.
- The storage location and any known excursion — a period out of the intended conditions is a fact worth recording even when its effect is unknown.
- The source of any interval you were given, and by whom. "The pharmacist who dispensed it said" is a citation; "someone online said" is not.14
An undated container is the failure case, and it is not a record with one blank. Once the date is gone it cannot be recovered from appearance, from purchase history, or from an average of habits, and a record that cannot be resolved cannot be handed to anyone as evidence of anything.
Is a beyond-use date just a shorter expiry date?
No. They are produced by different processes and answer different questions. An expiry date is an output of a stability programme on unopened containers. A beyond-use date is an output of the environment and process used to make or enter a preparation. One cannot be derived from the other.
Can a beyond-use date be later than the expiry date?
No. The beyond-use date is bounded by the manufacturer's expiration date for the same material. Compounding, entering or diluting a product does not extend the stability statement underneath it.
How long is something I prepared at home good for?
This page will not give a number, because no standard produces one for that setting. Expiry dating requires a stability programme, beyond-use dating requires a classified compounding environment, and an in-use period requires an approved label. Ask the pharmacy that dispensed the product, or the clinician who prescribed it, with the container in front of you.
Sources
- Regulatory21 CFR 211.137 — Expiration datingU.S. Electronic Code of Federal Regulations, 2026www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211/su ↗↩ Back to text
- Regulatory21 CFR 211.166 — Stability testingU.S. Electronic Code of Federal Regulations, 2026www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211/su ↗↩ Back to text
- RegulatoryQ1A(R2) Stability Testing of New Drug Substances and Products — Guidance for IndustryU.S. Food and Drug Administration, 2003www.fda.gov/regulatory-information/search-fda-guidance-documents ↗↩ Back to text
- Clinical guidelineUSP General Chapter <797> Pharmaceutical Compounding—Sterile PreparationsUnited States Pharmacopeia, 2023www.usp.org/compounding/general-chapter-797 ↗↩ Back to text
- Clinical guidelineWHO policy statement: Multi-dose vial policy (2014 revision)World Health Organization, 2014www.who.int/publications/i/item/WHO-IVB-14.07 ↗↩ Back to text
- Regulatory21 CFR 201.17 — Drugs; location of expiration dateU.S. Electronic Code of Federal Regulations, 2026www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-201/su ↗↩ Back to text
- RegulatoryCompounding and the FDA: Questions and AnswersU.S. Food and Drug Administration, 2026www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-que ↗↩ Back to text